Early intervention in psychosis: The critical-period hypothesis

International Clinical Psychopharmacology

Volumn 13, Issue SUPPL. 1, 1998, Pages

  Birchwood, Max ^a   Todd, Pauline ^a   Jackson, Chris ^a  

^a Early Intervention Service   (United Kingdom)

Author keywords

Critical period of psychosis; First psychotic episode; Intervention; Prospective studies; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

COGNITIVE THERAPY; CONFERENCE PAPER; DEPRESSION; DISEASE COURSE; DRUG ABUSE; EARLY DIAGNOSIS; EMOTION; FOLLOW UP; HUMAN; HYPOTHESIS; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; RECURRENCE RISK; RELAPSE; SCHIZOPHRENIA; SECONDARY PREVENTION; SOCIAL INTERACTION; SUICIDE;

EID: 0031906645     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199804004-00006     Document Type: Conference Paper

References (74)

1. Bebbington P, Kuipers L (1995). The predictive utility of expressed emotion in schizophrenia: an aggregate analysis. Psychol Med 24:707-718.
2. Beiser M, Jonathon AE, Fleming MB, Iacono WG, Lin T (1988). Refining the diagnosis of schizophreniform disorder. Am J Psychiatry 145:695-700.
3. Beiser M, Iacono WG, Erickson D (1989). Temporal stability in major mental disorders. In: The validity of psychiatric diagnosis. Robins LN, Barrett JE (editors). New York: Raven Press, pp. 77-98.
4. Biehl H, Maurer K, Schubart C, Krumm B, Jung E (1986). Prediction of outcome and utilisation of medical services in a prospective study of first onset schizophrenics: results of a prospective five-year follow-up study. Eur Arch Psychiatry Clin Neurosci 236:139-147.
5. Birchwood M (1992). Family factors in psychiatry. Curr Opin Psychiatry 5:295-299.
6. Birchwood M (1995). Early intervention in psychotic relapse: cognitive approaches to detection and management. Behav Change 12:2-19.
7. Birchwood M, Chadwick P (1997). The omnipotence of voices: testing the validity of a cognitive model. Psychol Med 27:1345-1353.
8. Birchwood M, Drury V (1995). Using the crisis. In: Emergency mental health services in the community. Phelan M, Strathdee G, Thornicroft G (editors). Cambridge: Cambridge University Press, pp. 82-109.
9. Birchwood M, Iqbal Z (in press). Depression and suicidal thinking in psychosis. In: Outcome and innovation in psychological treatment of schizophrenia. Wykes T, Tarrier N, Lewis S (editors). Chichester: Wiley.
10. Birchwood M, Macmillan F (1993). Early intervention in schizophrenia. Aust NZ J Psychiatry 27:374-378.
11. Birchwood M, Tarrier N (1994). The psychological management of schizophrenia. Chichester: Wiley.
12. Birchwood M, Hallett S, Preston M, editors (1988). Schizophrenia: an integrated approach to research and treatment. Harlow, Essex: Longman.
13. Birchwood M, Cochrane R, Macmillan J, Kucharska J, Cariss M (1992). The influence of ethnicity and family structure on relapse in first episode schizophrenia: a comparison of Asian, Caribbean and White patients. Br J Psychiatry 161:783-790.
14. Birchwood M, Mason R, Macmillan J, Healy J (1993). Depression, demoralisation and control over psychotic illness. Psychol Med 23:387-395.
15. Birchwood M, Chadwick P, Trower P (1996). Cognitive therapy for hallucinations, delusion and paranoia. Chichester: Wiley.
16. Birchwood M, McGorry P, Jackson H (1997). Early intervention in schizophrenia. Br J Psychiatry 170:2-5.
17. Bleuler M (1978). The schizophrenic disorders: long term patient and family studies. Clements S (translator). New Haven: Yale University Press.
18. Budd RJ, Hughes ICT, Smith JA (1996). Health beliefs and compliance with antipsychotic medication. Br J Clin Psychol 35:393-397.
19. Caldwell J, Gottesman I (1990). Schizophrenics kill themselves too. Schizophr Bull 16:571-590.
20. Carpenter W, Strauss J (1991). The prediction of outcome in schizophrenia. V. Eleven year follow-up of the IPSS cohort. J Nerv Mental Dis 179:517-525.
21. Chadwick P, Birchwood M (1994). Challenging the omnipotence of voices: a cognitive approach to auditory hallucinations. Br J Psychiatry 164:190-201.
22. Cotton P, Drake R, Gates C (1985). Critical treatment issues in schizophrenics. Hosp Commun Psychiatry 36:534-536.
23. DeLisi L, editor (1990). Depression in schizophrenia. Washington, DC: American Psychiatric Press.
24. Drake R, Gates C, Cotton P, Whittaker A (1985). Suicide among schizophrenics: who is at risk? J Nerv Ment Dis 172:613-617.
25. Drury V, Birchwood M, Cochrane R, Macmillan JF (1996). Cognitive therapy and recovery from acute psychosis: a controlled trial. Br J Psychiatry 169:593-607.
26. Dube K, Kumar N, Dube S (1984). Long-term course and outcome of the Agra cases in the International Pilot Study of Schizophrenia. Acta Psychiatr Scand 170:170-179.
27. Eaton W, Thara R, Federman B, Melton B, Kung-Yee Liang (1995). Structure and course of positive and negative symptoms in schizophrenia. Arch Gen Psychiatry 52:127-134.
28. Frank A, Gunderson J (1990). The role of the therapeutic alliance in the treatment of schizophrenia: relationship to course and outcome. Arch Gen Psychiatry 47:228-236.
29. Harrow M, MacDonald AW, Sands JR, Silverstein ML (1995). Vulnerability to delusions over time in schizophrenia and affective disorders. Schizophr Bull 21:95-109.
30. Helgason L (1990). Twenty years follow-up of first psychiatric prevention for schizophrenia: what could have been prevented? Acta Psychiatr Scand 81:231-235.
31. Herz M, Glazer W, Mostert M, Sheard MA, Szymanski HV, Hafez H, et al. (1991). Intermittent vs. maintenance medication in schizophrenia. Arch Gen Psychiatry 48:333-337.
32. Hirschberg W (1985). Social isolation among schizophrenic out-patients. Soc Psychiatry 20:171-178.
33. Jablensky A, Sartorious N, Emberg G, Anker M, Korten A, Cooper J, Bertelson A (1992). Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organisation Ten Country Study. Psychol Med suppl 20:1-97.
34. Jackson C, Birchwood M (1996). Early intervention in psychosis: opportunities for secondary prevention. Br J Clin Psychol 35:487-502.
35. Jackson J, Edwards J (1992). Social networks and social support in schizophrenia. In: Schizophrenia: an overview and practical handbook. Kavanagh D (editor). London: Routledge. pp. 215-242.
36. Johnson D (1981). Studies of depressive symptoms in schizophrenia. Br J Psychiatry 139:89-101.
37. Johnstone EC, Crow TJ, Johnson AL, Macmillan, JF (1986). The Northwick Park study of first episode schizophrenia. I. Presentation of the illness and problems relating to admission. Br J Psychiatry 148:115-120.
38. Johnstone EC, Macmillan JF, Frith CD, Benn DK, Crow TJ (1990). Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry 157: 182-189.
39. Johnstone E, Frith C, Crow T, Owen D, Done D, Baldwin E, Charlette A (1992). The Northwick Park functional psychosis study: diagnosis and outcome. Psychol Med 22:331-346.
40. Jones PB, Bebbington P, Foerster A, Lewis SW, Murray RM, Russell A, et al. (1993). Premorbid social underachievement in schizophrenia: results from the Camberwell collaborative psychosis study. Br J Psychiatry 162:65-71.
41. Kane JM (1983). Low dosage medication strategies in the maintenance treatment of schizophrenia. Schizophr Bull 9:528-531.
42. Kane JM (1989). The current status of neuroleptics. J Clin Psychiatry 50:322-328.
43. Kane JM, Honigfeld G, Singer J, Meltzer HY (1988). Clozapine in the treatment-resistant schizophrenic: a double-blind comparison of chloroprozanine Arch Gen Psychiatry 45:789-796.
44. Kavanagh D (1992). Recent developments in expressed emotion and schizophrenia. Br J Psychiatry 160:601-620.
45. Kingdon DG, Turkington D (1994). Cognitive-behavioural therapy of schizophrenia. Brighton: Lawrence Erlbaum Associates.
46. Kraepelin E (1896). Dementia praecox. In: The clinical roots of schizophrenia. Translated into English, 1987. Cutting J, Shepherd M (editors). Cambridge: Cambridge University Press.
47. Kuipers E, Garety P, Fowler D, Dunn G, Bebbington P, Freeman D, Healy C (1997). London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I. Effects of the treatment phase. Br J Psychiatry 171:319-327.
48. Linszen D, Dingemans P, Lenior M (1994). Cannabis abuse and the course of recent onset schizophrenic disorders. Arch Gen Psychiatry 51:273-279.
49. Linszen D, Dingemans P, Van der Does J, Nugter A, Scholte P, Lenior R, Goldstein MJ (1996). Treatment, expressed emotion and relapse in recent onset schizophrenia. Psychol Med 26:333-342.
50. Marder S, Wirsching WC, Van Putten J, Mintz J, Mckenzie J, Johnston-Cronk K, et al. (1994). Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia. Arch Gen Psychiatry 51:280-287.
51. Mason P, Harrison G, Glazebrook C, Medley I, Dalkin T, Croudace T (1995). Characteristics of outcome in schizophrenia at 13 years. Br J Psychiatry 167:596-603.
52. Mason P, Harrison G, Glazebrook C, Medley I, Croudace T (1996). The course of schizophrenia over 13 years. Br J Psychiatry 169:580-586.
53. May P, Tuma A, Dixon W (1976). Schizophrenia: a follow up study of results of treatment. I. Design and other problems. Arch Gen Psychiatry 33:474-478.
54. McEvoy JP, Hogarty EE, Steingard S (1991). Optimal dose of neuroleptic in acute schizophrenia. Arch Gen Psychiatry 48:739-745.
55. McGlashan T (1988). A selective review of North American long term follow-up studies of schizophrenia. Schizophr Bull 14:515-542.
56. McGlashan T, Carpenter W (1976). Post-psychotic depression in schizophrenia. Arch Gen Psychiatry 33:231-239.
57. McGorry PD, Chanen A, McCarthy E, Van Reil R, McKenzie D, Singh B (1991). Post-traumatic stress disorder following recent onset psychosis. An unrecognised postpsychotic syndrome. J Nerv Ment Dis 179:253-258.
58. Mortenson PB, Juel K (1993). Mortality and the causes of death in first admitted schizophrenic patients. Br J Psychiatry 163:183-189.
59. Mueser KT, Bellack AS, Morrison RL, Wade JH (1990). Gender, social competence and symptomatology in schizophrenia: a longitudinal analysis. J Abnorm Psychol 9:138-147.
60. Pilovsky LS, Kerwin RW, Murray RM (1993). Schizophrenia: a neurodevelopmental perspective. Neuropsychopharmacology 9:83-91.
61. Price J, Sloman L, Gardner R, Gilbert P, Rohde P (1994). The social competition hypothesis of depression. Br J Psychiatry 164:309-315.
62. Ram R, Bromet EJ, Eaton WW, Pato C, Schwarz JE (1992). The natural course of schizophrenia: a review of first admission studies. Schizophr Bull 18:185-207.
63. Roy A (1986). Suicide in schizophrenia. In: Suicide. Roy A (editor). Baltimore: Williams and Wilkins. pp. 202-222.
64. Schubart C, Krumm B, Biehl H, Schwarz R (1986). Measure of social disability in a schizophrenic patient group: definition, assessment and outcome over 2 years in a cohort of schizophrenic patients of recent onset. Soc Psychiatry 21:1-9.
65. Scottish Schizophrenia Research Group (1988).The Scottish first episode schizophrenia study vs. one year follow-up. Br J Psychiatry 152:470-476.
66. Scottish Schizophrenia Research Group (1992).The Scottish first episode schizophrenia study. VIII. Five year follow-up: clinical and psychosocial findings. Br J Psychiatry 161:496-500.
67. Shepherd M, Watt D, Fallon I, Smeeton N (1989). The natural history of schizophrenia: a five year follow-up in a representative sample of schizophrenics. Psychol Med 19 (suppl 15):1-46.
68. Stirling J, Tantam D, Thonks P, Newby D, Montague L (1991). Expressed emotion and early onset schizophrenia. Psychol Med 21:675-685.
69. Strauss J, Carpenter WT (1977) Prediction of outcome in schizophrenia. III. Five year outcome and its predictors. Arch Gen Psychiatry 34:159-163.
70. Thornicroft G, Breakey W (1991). The COSTAR Programme. 1. Improving social networks of the long-term mentally ill. Br J Psychiatry 159:245-259.
71. Warner R (1994). Recovery from schizophrenia: psychiatric and political economy. London: Routledge.
72. Warner R, Taylor D, Powers M, Hyman J (1989). Acceptance of the mental illness label by psychotic patients: effects on functioning. Am J Orthopsychiatry 59:398-409.
73. Westermeyer JF, Harrow M, Marengo JT (1991). Risk for suicide in schizophrenia and other psychotic and non-psychotic disorders. J Nerv Ment Dis 179:259-266.
74. Wyatt RJ (1991). Neuroleptics and the natural course of schizophrenia. Schizophr Bull 17:325-351.